Ashlyn Anderson, Lauren Dickey, Darcie Draudt, Andrew Hill, Will Piekos, and Sharone Tobias look at the top stories in Asia today.
1. China fines GlaxoSmithKline nearly $500 million for bribery. A Chinese court fined British pharmaceuticals firm GlaxoSmithKline (GSK) 3 billion yuan ($489 million) after the one-day, closed-door trial ended, finding the company guilty of bribery. Several officials of the company, including Mark Reilly, the former head of GSK in China, were also given suspended jail sentences. GSK said that it remained committed to operating in China despite the ruling. The company is also being investigated in the United States under the Foreign Corrupt Practices Act, and has been accused of corrupt practices on smaller scales in Poland, Syria, Iraq, Jordan, and Lebanon. By some estimates, GSK’s actions in China led to over $150 million in illegal revenues. Read more »